ZURICH, Oct 1 (Reuters) – Novartis’s psoriasis drug
Cosentyx showed long-term efficacy in keeping patients’ skin
clear, the Swiss drugmaker said on Saturday, citing a study it
hopes will ultimately…
The post Novartis psoriasis drug maintains efficacy after 4 years – study appeared first on NASDAQ.